changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
As the use of minimally invasive therapies continues to grow, we have the financial resources and capabilities to continue to make targeted new investments, so that we can continue building our Interventional Medicine business and developing leadership positions in attractive growth markets.
With our financial resources and capabilities, I am confident our strategy will create long-term value for all our stakeholders.
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com